浅谈口服缓控释制剂在高血压治疗中的临床应用  

Clinical Application of Orally Sustained Release Preparations in the Treatment of Hypertension

作　　者：李艳凤[1] 

机构地区：[1]郑州市第七人民医院药学部,450016

出　　处：《中国卫生标准管理》2015年第28期100-101,共2页China Health Standard Management

摘　　要：目的促进临床更加安全、有效、合理的使用缓控释制剂。方法通过介绍缓控释制剂的剂型特点,以及在高血压治疗中临床应用所存在的诸多问题,了解常用的口服缓控释制剂的使用方法及注意事项。结果缓控释制剂在临床应用中存在用法、用量、给药频次等错误。结论临床药师加强药学监护,采取干预措施,使缓控释制剂的应用更安全、有效、合理。Objective In order to promote clinical use of sustained and controlled release creparations more safely,effectively and reasonablely. Methods By introducing the characteristics of Sustained and controlled release preparations and some problems of clinical application in treatment of hypertension,to understand the commonly methods of use and matters needing attention. Results There were usage,dosage and frequency problems in the application. Conclusion The pharmaceutical care should be strengthened by clinical pharmacists and Interventions should be used to promote clinical use more safely,effectively and reasonablely.

关 键 词：缓控释制剂 高血压 临床应用 

分 类 号：R972[医药卫生—药品]